Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Willdan Group
WLDN
$1.55B
| $365K | ﹤0.01% |
+12,600
| New | +$365K |
|
3002
Coherus Oncology, Inc. Common Stock
CHRS
$155M
| $364K | ﹤0.01% |
+152,328
| New | +$364K |
|
3003
Steelcase
SCS
$1.95B
| $364K | ﹤0.01% |
27,800
-143,100
| -84% | -$1.87M |
|
3004
Capricor Therapeutics
CAPR
$294M
| $361K | ﹤0.01% |
53,150
-93,171
| -64% | -$633K |
|
3005
Karooooo
KARO
$1.71B
| $361K | ﹤0.01% |
14,401
+1,900
| +15% | +$47.6K |
|
3006
Cartesian Therapeutics
RNAC
$259M
| $360K | ﹤0.01% |
18,453
+1,193
| +7% | +$23.3K |
|
|
ZH
3007
Zhihu
ZH
$455M
| $360K | ﹤0.01% |
87,617
| – | – |
|
|
VBNK
3008
VersaBank
VBNK
$390M
| $358K | ﹤0.01% |
33,815
+21,315
| +171% | +$226K |
|
|
XYF
3009
X Financial
XYF
$581M
| $358K | ﹤0.01% |
92,675
-2,900
| -3% | -$11.2K |
|
3010
Direxion Daily Real Estate Bear 3X Shares
DRV
$40.9M
| $357K | ﹤0.01% |
+10,200
| New | +$357K |
|
3011
Oramed Pharmaceuticals
ORMP
$99.6M
| $357K | ﹤0.01% |
122,100
-218,973
| -64% | -$640K |
|
3012
REE Automotive
REE
$20.4M
| $357K | ﹤0.01% |
61,077
+3,600
| +6% | +$21K |
|
3013
iShares MSCI Pacific ex Japan ETF
EPP
$1.87B
| $355K | ﹤0.01% |
+8,300
| New | +$355K |
|
3014
GEE Group
JOB
$20.8M
| $355K | ﹤0.01% |
987,629
+90,237
| +10% | +$32.4K |
|
|
NREF
3015
NexPoint Real Estate Finance
NREF
$270M
| $355K | ﹤0.01% |
24,700
-6,000
| -20% | -$86.2K |
|
3016
Steven Madden
SHOO
$2.31B
| $355K | ﹤0.01% |
8,400
-153,300
| -95% | -$6.48M |
|
3017
UTStarcom
UTSI
$23.7M
| $355K | ﹤0.01% |
136,629
-16,897
| -11% | -$43.9K |
|
3018
Avantis Emerging Markets Equity ETF
AVEM
$12.7B
| $354K | ﹤0.01% |
+6,100
| New | +$354K |
|
3019
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.32B
| $354K | ﹤0.01% |
14,883
+1,494
| +11% | +$35.5K |
|
3020
Bristow Group
VTOL
$1.1B
| $354K | ﹤0.01% |
13,000
-12,300
| -49% | -$335K |
|
3021
Sonos
SONO
$1.83B
| $353K | ﹤0.01% |
+18,500
| New | +$353K |
|
3022
-1x Short VIX Futures ETF
SVIX
$196M
| $352K | ﹤0.01% |
+8,300
| New | +$352K |
|
|
VZLA
3023
Vizsla Silver
VZLA
$1.34B
| $352K | ﹤0.01% |
265,000
-76,152
| -22% | -$101K |
|
3024
Sportsman's Warehouse
SPWH
$118M
| $350K | ﹤0.01% |
112,700
+66,400
| +143% | +$206K |
|
3025
iShares MSCI World ETF
URTH
$5.73B
| $348K | ﹤0.01% |
2,400
-9,700
| -80% | -$1.41M |
|